J&J's pancreatic-enzyme treatment Pancreaze gains FDA approval

04/12/2010 | Reuters

The FDA approved Pancreaze for use in patients with cystic fibrosis and other conditions caused by pancreatic-enzyme deficiency. The treatment, developed by Johnson & Johnson, will compete with pancreatic-enzyme products from Eurand and Abbott Laboratories.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC